Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ARWR: Arrowhead Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ARWR
The Story
ARWR
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+23258.2% / yr
Operating margin
-35.7%
ROIC
-11.0%
Financially safe
Stretched
Debt / equity
2.24×
Interest coverage
-2.4×
Current ratio
6.23×
Arrowhead Pharmaceuticals, Inc.
ARWR
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Arrowhead Pharmaceuticals, Inc.
ARWR
NASDAQ
·
USD
·
Closed
$84.65
−3.06%
$84.65
−$2.67 (3.06%)
52W Range
87th
pctl
Volume
0.74×
avg
Mkt Cap
11.92B
USD
P/E
-39.6
TTM
Div Yield
–
ann
52W Range
87th
pctl
Volume
0.74×
avg
Market Cap
11.92B
USD
P/E Ratio
-39.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings